This course explores the risk factors for opioid misuse and reviews the classification of opioid use disorder. It also provides an overview of assessment and management tools and strategies that can be employed to ensure safe and effective pain management for patients using opioid medications.
This course explores the risk factors for opioid misuse and reviews the classification of opioid use disorder. It also provides an overview of assessment and management tools and strategies that can be employed to ensure safe and effective pain management for patients using opioid medications.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
South Carolina Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.75 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Physicians will receive 0.75 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 0.75 AMA PRA category 1 Credits™
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: The Opioid Epidemic
Meet Josephine
Prevalence of Opioid Use
Opioid Misuse and Opioid Use Disorder
Review
Summary
Section 3: Risk Assessment
Identifying Risk Factors for OUD
Prescribing Guidelines
Avoiding Overdose and Other Opioid-related Harms
Review
Summary
Section 4: Opioid-Specific Risk Assessment in Practice
The Opioid Risk Tool (ORT)
The SOAPP®-R
Review
Summary
Section 5: Conclusion
Course Summary
Course Contributors
Resources
References
Subject Matter Expert: Daisy Goodman, DNP, MPH, APRN, CNMClaire Hartman, RN, BSN, IBCLC is a SME nurse writer for Relias in Acute Care. She has nursing experience in functional medicine, neonatal intensive care, and obstetrics. Ms. Hartman has over 10 years of experience in birth, with a focus on high-risk obstetrics and perinatal hospice. She is an Internationally Board Certified Lactation Consultant and has taught neonatal resuscitation, breastfeeding support, and routine gynecological care to providers in varied medical settings. Ms. Hartman has led a community support group for bereaved families experiencing perinatal loss.
Disclosure: Claire Hartman, RN, IBCLC has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Daisy Goodman, DNP, MPH, APRN, CNM, is a certified nurse midwife and Clinical Assistant Professor of Obstetrics and Gynecology at the Geisel School of Medicine at Dartmouth. She currently directs women's health services at the Dartmouth Hitchcock Moms in Recovery Program and teaches healthcare quality improvement at The Dartmouth Institute. Her research focuses on improving access to substance use treatment for women through integrated delivery models and the intersection between women's healthcare and treatment for substance use. She was one of thefirst wave of advanced practice nurses in New Hampshire to obtain a waiver to prescribe buprenorphine. She currently leads a three -year dissemination and implementation project to improve maternity care for women with opioid use disorders, sponsored by the Northern New England Perinatal Quality Improvement Network. Disclosure: Daisy Goodman, DNP, MPH, APRN, CNM has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.